Discovery of dipiperidines as new antitubercular agents
As part of our ongoing research effort to develop new therapeutics for treatment of tuberculosis (TB), we synthesized a combinatorial library of 10,358 compounds on solid support using a pool-and-split technique and tested the resulting compounds for activity against Mycobacterium tuberculosis. Stru...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 20; no. 1; pp. 201 - 205 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier Ltd
01.01.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | As part of our ongoing research effort to develop new therapeutics for treatment of tuberculosis (TB), we synthesized a combinatorial library of 10,358 compounds on solid support using a pool-and-split technique and tested the resulting compounds for activity against
Mycobacterium
tuberculosis. Structure–activity relationship (SAR) evaluation identified new compounds with antitubercular activity, including a novel hit series that is structurally unrelated to any existing antitubercular drugs, dipiperidines. Dipiperidine representatives exhibited MIC values as low as 7.8
μM, the ability to induce promoter Rv0341 activated in response to cell wall biosynthesis inhibition, relatively low nonspecific cellular toxicity in the range of 30–162
μM, and log
P values less than 4. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: John Hopkins School of Medicine & John Hopkins School of Public Health, Baltimore, MD, USA Present address: Aeras Global TB Vaccine Foundation, 1405 Research Blvd., Rockville, MD 20850, USA Corresponding author. Tel.: +1 301-762-7776; fax: 301-762-7778; elenabogatcheva@sequella.com Present address: National Institute of Health (NIH), NIAID, 6610 Rockledge Dr., Bethesda MD, USA |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2009.10.135 |